Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03484 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Zhilong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanji…. Hauptthemen laut MEDLINE: Lactams, Antineoplastic Agents, Drug Discovery. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Project 211, Ministry of Science and Technology of the People's Republic of China, China Pharmaceutical University.
Abstract (Originalsprache)
Based on compound 1, a previously identified activator of human caseinolytic protease P (hClpP) containing a pyrazololactam scaffold, a class of benzolactam derivatives was designed through a scaffold-hopping strategy. Structural optimization of this series led to the identification of LZL25, which potently activated recombinant hClpP with an EC 50 of 0.36 μM and inhibited the growth of MDA-MB-231 cells with an IC 50 of 0.29 μM. Mechanistic studies showed that LZL25 strongly bound to and activated cellular hClpP, effectively promoted the degradation of hClpP substrates in cells, and robustly induced apoptosis in MDA-MB-231 cells. Further optimization yielded LZL50, which demonstrated favorable pharmacokinetic properties and exhibited potent antitumor activity in an MDA-MB-231 xenograft mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Drug Design and Optimization, Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China.
- Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.
- Chongqing Innovation Institute of China Pharmaceutical University, Chongqing 401151, China.
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education, Yunnan University, Kunming 650500, China.
- Yunnan Key Laboratory of Research and Development for Natural Products, School of Pharmacy, Yunnan University, Kunming 650500, China.
ORCID-Profile: Haiying Sun
Förderung
- Project 211
- Ministry of Science and Technology of the People's Republic of China
- China Pharmaceutical University
- Program for Jiangsu Province Innovative Research Team and Personnel
- Yunnan Province
Zitieren
APA
Li, Z., Chen, Z., Luo, J., Wang, Y., Jin, Y., Kong, L., Li, Y., Xiao, Y., & Sun, H. (2026). Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03484
Vancouver
Li Z, Chen Z, Luo J, Wang Y, Jin Y, Kong L, et al. Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03484
BibTeX
@article{Li2026,
author = {Li, Zhilong and Chen, Ziyuan and Luo, Jiajun and Wang, Yuyang and Jin, Yiquan and Kong, Lingmei and Li, Yan and Xiao, Yibei and Sun, Haiying},
title = {Discovery of Activators of Human Caseinolytic Protease P with a Benzolactam Scaffold},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03484}
}
EUVIMED